A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with nonalcoholic fatty liver disease: preliminary observations

被引:67
作者
Federico, A. [1 ]
Trappoliere, M. [1 ]
Tuccillo, C. [1 ]
de Sio, I. [1 ]
Di Leva, A. [1 ]
Blanco, C. Del Vecchio [1 ]
Loguercio, C. [1 ]
机构
[1] Univ Naples 2, CIRANAD, Gastroenterol Unit, Interuniv Res Ctr Foods Nutr & Gastrointestinal T, I-80131 Naples, Italy
关键词
D O I
10.1136/gut.2006.091967
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:901 / 902
页数:4
相关论文
共 9 条
[1]  
Bean Pamela, 2002, Am Clin Lab, V21, P19
[2]   Nonalcoholic steatohepatitis: Definition and pathology [J].
Brunt, EM .
SEMINARS IN LIVER DISEASE, 2001, 21 (01) :3-16
[3]   HISTOLOGICAL GRADING AND STAGING OF CHRONIC HEPATITIS [J].
ISHAK, K ;
BAPTISTA, A ;
BIANCHI, L ;
CALLEA, F ;
DEGROOTE, J ;
GUDAT, F ;
DENK, H ;
DESMET, V ;
KORB, G ;
MACSWEEN, RNM ;
PHILLIPS, MJ ;
PORTMANN, BG ;
POULSEN, H ;
SCHEUER, PJ ;
SCHMID, M ;
THALER, H .
JOURNAL OF HEPATOLOGY, 1995, 22 (06) :696-699
[4]  
JOSEPH AE, 1991, CLIN RADIOL, V9, P91
[5]   WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance [J].
Melchionda, N ;
Forlani, G ;
Marchesini, G ;
Baraldi, L ;
Natale, S .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (01) :90-96
[6]  
Patrick L, 1999, Altern Med Rev, V4, P220
[7]   Serum markers detect the presence of liver fibrosis: A cohort study [J].
Rosenberg, WMC ;
Voelker, M ;
Thiel, R ;
Becka, M ;
Burt, A ;
Schuppan, D ;
Hubscher, S ;
Roskams, T ;
Pinzani, M ;
Arthur, MJP .
GASTROENTEROLOGY, 2004, 127 (06) :1704-1713
[8]   Obesity and non-alcoholic fatty liver disease in chronic hepatitis C [J].
Younossi, ZM ;
McCullough, AJ ;
Ong, JP ;
Barnes, DS ;
Post, A ;
Tavill, A ;
Bringman, D ;
Martin, LM ;
Assmann, J ;
Gramlich, T ;
Mullen, KD ;
O'Shea, R ;
Carey, WD ;
Ferguson, R .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (08) :705-709
[9]   Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention [J].
Zhao, JF ;
Agarwal, R .
CARCINOGENESIS, 1999, 20 (11) :2101-2108